|
1
|
Schachat AP: Ophthalmology retina.
Ophthalmol Retina. 1:22017. View Article : Google Scholar
|
|
2
|
Ding H, Smith RG, Poleg-Polsky A, Diamond
JS and Briggman KL: Species-specific wiring for direction
selectivity in the mammalian retina. Nature. 535:105–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vecino E, Rodriguez FD, Ruzafa N, Pereiro
X and Sharma SC: Glia-neuron interactions in the mammalian retina.
Prog Retin Eye Res. 51:1–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan SM, Deliyanti D, Figgett WA, Talia DM,
de Haan JB and Wilkinson-Berka JL: Ebselen by modulating oxidative
stress improves hypoxia-induced macroglial Müller cell and vascular
injury in the retina. Exp Eye Res. 136:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin J and Chen RWS: Central serous
chorioretinopathyManual of Retinal Diseases. Medina CA, Townsend JH
and Singh AD: 1st edition. Springer International Publishing; Cham:
pp. 421–426. 2016, View Article : Google Scholar
|
|
6
|
Lavinsky D and Palanker D: Nondamaging
photothermal therapy for the retina: Initial clinical experience
with chronic central serous retinopathy. Retina. 35:213–222. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Breukink MB, den Hollander AI, Keunen JE,
Boon CJ and Hoyng CB: The use of eplerenone in therapy-resistant
chronic central serous chorioretinopathy. Acta Ophthalmol.
92:e488–e490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keles S, Ates O, Kartal B, Alp HH, Ekinci
M, Ceylan E, Ondas O, Arpali E, Dogan S, Yildirim K, et al:
Evaluation of cardiovascular biomarkers in patients with
age-related wet macular degeneration. Clin Ophthalmol. 8:1573–1578.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yau G, Almeida DRP, Chin EK and Park SS:
Acquired macular disordersHandbook of Vitreo-Retinal Disorder
Management: A Practical Reference Guide. Park SS: 1st edition.
World Scientific Publishing Co.; Singapore: pp. 31–70. 2015
|
|
10
|
Marcuson J and Thomas R: Central serous
chorioretinopathy. Optometry. 79:241–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liegl R and Ulbig MW: Central serous
chorioretinopathy. Ophthalmologica. 232:65–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wolf S and Wolf-Schnurrbusch U:
Spectral-domain optical coherence tomography use in macular
diseases: A review. Ophthalmologica. 224:333–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daruich A, Matet A, Dirani A, Bousquet E,
Zhao M, Farman N, Jaisser F and Behar-Cohen F: Central serous
chorioretinopathy: Recent findings and new physiopathology
hypothesis. Prog Retin Eye Res. 48:82–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim JW, Kang SW, Kim YT, Chung SE and Lee
SW: Comparative study of patients with central serous
chorioretinopathy undergoing focal laser photocoagulation or
photodynamic therapy. Br J Ophthalmol. 95:514–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Costanzo E, Cohen SY, Miere A, Querques G,
Capuano V, Semoun O, El Ameen A, Oubraham H and Souied EH: Optical
coherence tomography angiography in central serous
chorioretinopathy. J Ophthalmol. 2015:1347832015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maftouhi Quaranta-El M, El Maftouhi A and
Eandi CM: Chronic central serous chorioretinopathy imaged by
optical coherence tomographic angiography. Am J Ophthalmol.
160(581–587): e12015.
|
|
17
|
McClintic SM, Jia Y, Huang D and Bailey
ST: Optical coherence tomographic angiography of choroidal
neovascularization associated with central serous
chorioretinopathy. JAMA Ophthalmol. 133:1212–1214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Herrera Siklódy C, Arentz T, Minners J,
Jesel L, Stratz C, Valina CM, Weber R, Kalusche D, Toti F, Morel O,
et al: Cellular damage, platelet activation, and inflammatory
response after pulmonary vein isolation: A randomized study
comparing radiofrequency ablation with cryoablation. Heart Rhythm.
9:189–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaya MG, Yarlioglues M, Gunebakmaz O,
Gunturk E, Inanc T, Dogan A, Kalay N and Topsakal R: Platelet
activation and inflammatory response in patients with non-dipper
hypertension. Atherosclerosis. 209:278–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hileman C, Longenecker C, Carman T, Milne
G, Labbato DE, Storer Nj, White C and McComsey G: Relationship
between total bilirubin and endothelial function, inflammation and
oxidative stress in HIV-infected adults on stable antiretroviral
therapy. HIV Med. 13:609–616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akboga MK, Canpolat U, Sahinarslan A,
Alsancak Y, Nurkoc S, Aras D, Aydogdu S and Abaci A: Association of
serum total bilirubin level with severity of coronary
atherosclerosis is linked to systemic inflammation.
Atherosclerosis. 240:110–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao SL: The role of bilirubin and
phototherapy in the oxidative/antioxidant balance. Pediatr
Neonatol. 56:77–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Widowati W, Herlina T, Ratnawati H, Mozef
T and Immanuel V: Potency of antioxidant, anticholesterol and
platelet antiaggregation of black tea (Camelia sinensis).
Bul Littro. 22:74–83. 2011.
|
|
24
|
Sadiq MA, Hanout M, Sarwar S, Hassan M,
Agarwal A, Sepah YJ, Do DV and Nguyen QD: Platelet-derived growth
factor inhibitors: A potential therapeutic approach for ocular
neovascularization. Dev Ophthalmol. 55:310–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
